65,437 trials
COPD
Primary: Mixed Model for Repeated Measures (MMRM): Between-treatment Comparisons for Trough FEV1 (L) on Day 85 — 1.270; 1.215; 1.277; 1.228 Liters
Pneumonia
Primary: Length of Hospital Stay — 7.3; 5.8 Days
Chemotherapy-Induced Nausea and Vomiting
Primary: Percentage of Patients With Adverse Events — 86.0; 91.3 percentage of patients with TEAE
Femur Neck Fracture
Primary: Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture — 74; 93 Percentage of participants
Contour Irregularity of Reconstructed Breast
Primary: Breast Projection — 19.8205 percentage loss of projection
Skin Aging
Primary: Improvement in Laxity — 0.6; 1.0; 0.9; 1.3 units on a scale
Depression · Information Dissemination · Social Determinants of Health
Primary: Percent of Participants With Poor Mental Health Quality of Life, MCS12≤ 40 — 51.4; 44.1 percentage of participants
Stress Disorders, Post-Traumatic · Sleep Initiation and Maintenance Disorders
Primary: Perceived Sleep Quality — 2.8; 2.6; 2.3; 2.8 units on a scale
Gastrinoma · Glucagonoma · Insulinoma
Primary: Confirmed Response Rate — 10; 14 percentage of participants
HIV Infections · Pneumococcal Infections
Primary: Geometric Mean Fold Rise (GMFR) for Serotype-Specific Pneumococcal Immunoglobulin G (IgG) Antibody From 1 Month After 13vPnC Dose 2 to 1 Month After 13vPnC Dose 3 in All…
Spondyloarthritis · Enterocolitis
Primary: Change Lewis Score Index — -225 units on a scale
Lung Cancer
Primary: M.D. Anderson Symptom Inventory (MDASI) — 33.91; 20.91; 33.04; 22.86 units on a scale — p=<.05
Mantle Cell Lymphoma
Primary: Progression Free Survival (PFS) — 437.0; 751.0 Days — p=<0.001
Metastatic Progressive Castration-resistant Prostate Cancer
Primary: Change From Baseline in Bone Marrow Testosterone — 0.05 ng/mL
Femur Neck Fracture
Primary: Percentage of Participants With No Revision Surgery at 12 Months After Internal Fixation of a Low-Trauma Femoral Neck Fracture — 87; 86 percentage of participants